A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin’s lymphoma: A randomized trial.

Hsu, CCHsuHsiung, CACAHsiungSu, IJIJSuHwang, WSWSHwangWang, MCMCWangLin, SFSFLinLin, THTHLinHsiao, HHHHHsiaoYoung, JHJHYoungChang, MCMCChangLiao, YMYMLiaoLi, CCCCLiWu, HBHBWuTien, HFHFTienCho, TYTYChoLiu, TWTWLiuCheng, ALALChengChen, PJPJChen2010-10-222018-07-062010-10-222018-07-062008-03http://ntur.lib.ntu.edu.tw//handle/246246/218909en-US[SDGs]SDG3A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin’s lymphoma: A randomized trial.